Image_5_Clinical Outcomes Following Hemodynamic Parameter or Intravascular Imaging-Guided Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents: An Updated Systemati... by Meng-Jin Hu (11928965)

Image_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_3_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Table_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.docx by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Table_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.docx by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_2_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_3_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_2_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

DataSheet_1_Identification and experimental validation of cuproptosis regulatory program in a sepsis immune microenvironment through a combination of single-cell and bulk RNA seque... by Tingru Zhao (17368789)

“…Patients with higher CuAS exhibited prominent strength and numbers of cell–cell interactions. A total of five CRGs were identified based on the LASSO and Cox regression analyses, and a CRG-based risk model was established. …”

Analysis of glycine and proliferation <i>in vitro</i> as a function of SHMT2 and sodium benzoate. by Jiefei Tong (426705)

“…Intracellular metabolites were extracted and analyzed by selected reaction monitoring mass spectrometry, SRM, n = 5 to 8 biological replicates. (A) In HeLa-Ss cells relative levels of intracellular glycine levels were measured as a function of endogenous SHMT2 expression (control; C) or elevated (+) or decreased (–) expression of SHTM2 (described above), and without (–) or with (+) glycine supplementation in growth medium. …”

VEGF immunoperoxidase in kidneys of 17-GD LP progeny compared to NP offspring. by Julia Seva Gomes (15411772)

GJIC has a dual effect on Cd-induced cytotoxic injury. by Hui Zou (666389)

“…<p><b>a</b>: Effect of Sal on the Cd-induced down-regulation of GJIC in BRL 3A cells and rat liver tissue(Cd 2.5 means 2.5μm Cd, Cd 10 means 10μm Cd). …”

Image_1_Specific immune responses after BNT162b2 mRNA vaccination and COVID-19 infection.jpeg by Simona Arientová (17177131)

“…After two doses, specific T cell responses were detected in 87.5% of the vaccinated group. Additionally, there was a significant decrease before the third dose. …”

Table_1_Specific immune responses after BNT162b2 mRNA vaccination and COVID-19 infection.docx by Simona Arientová (17177131)

“…After two doses, specific T cell responses were detected in 87.5% of the vaccinated group. Additionally, there was a significant decrease before the third dose. …”

HIF-1α immunoperoxidase in kidneys of 17-GD LP progeny compared to NP offspring. by Julia Seva Gomes (15411772)

Comparison of the accurate structural coefficient<i>σ</i>_<i>ac</i> and the approximate one <i>σ</i>_<i>ap</i> across the parameter space (<i>v</i>, <i>u</i>).... by Yanling Zhang (6561)

“…The relative difference of <i>σ</i>_<i>ac</i> and <i>σ</i>_<i>ap</i>, |<i>σ</i>_<i>ac</i>−<i>σ</i>_<i>ap</i>|/<i>σ</i>_<i>ac</i>, decreases as <i>N</i> rises (each column) or as <i>M</i> diminishes (each row), and it is small when <i>u</i> or <i>v</i> is low (each panel). …”

Correlation analysis and functional annotation of DEmRNAs in Module 1. by Mina Baek (12481649)

Fluorofoldamer-Based Salt- and Proton-Rejecting Artificial Water Channels for Ultrafast Water Transport by Jie Shen (31533)

“…Produced by a facile one-pot copolymerization reaction under mild conditions, the best-performing channel (AWC <b>1</b>) is an n-C₈H₁₇-decorated foldamer nanotube with an average channel length of 2.8 nm and a pore diameter of 5.2 Å. …”

Supplementary Material for: Orbital edema secondary to a sphenoidal mass as the presenting symptom of high-risk precursor B cell acute lymphoblastic leukemia: a case report by Lo C. (17704092)